PDI extends sales service agreement with top-10 pharma company

Share this article:

PDI, Inc. announced that it has extended its sales services agreement with a top-10 pharma company through April 2009 to promote its anti-viral medication on a seasonal basis. This initiative is expected to generate approximately $10.5M during the 2007-2008 season, PDI said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.